For the year so far, FIIs have been net sellers of shares worth Rs 1.15 lakh crore, while DIIs have net bought Rs 3.48 lakh crore worth of shares.

When mifepristone, sometimes known as the abortion pill, was approved by the FDA in 2000, it was placed under a strict Risk Evaluation and Mitigation Strategy (REMS) due to serious safety concerns ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

Attorneys general of New York, California, New Jersey and Massachusetts are asking the Food and Drug Administration (FDA) to expand access to the abortion pill and remove some “unnecessary ...

FDA Commissioner Marty Makary committed to Sen. Josh Hawley that the agency will conduct a safety review of the abortion pill mifepristone.

Chime Financial Inc. and some of its shareholders are seeking to raise as much as $832 million from an initial public offering, which could give the San Francisco-based fintech a fully diluted ...

The Department of Justice on Monday said a lawsuit against the Food and Drug Administration seeking to sharply restrict the abortion pill mifepristone should be dismissed, continuing the position o… ...

Apple’s Beats brand brought the iconic Beats Pill back from the dead last summer. Now, the company is refreshing the lineup with two new colors for Beats Pill shoppers: Navy Blue and Blush Pink ...

Watch on The new Navy Blue Beats Pill from Walmart and Blush Pink Beats Pill from Target are available starting today at the same $149.99 price point as the standard colors.

Regardless of the color you get the Beats Pill in, you’re scoring what Beats is now confirming is “its bestselling speaker" ever, in that it's sold more of the new Beats Pill in the nine ...

Eli Lilly's new oral weight loss pill, orforglipron, shows promise in Phase 3 trials, offering a convenient alternative to injectable GLP-1 drugs like Ozempic and Mounjaro. With significant weight ...